Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Bladder Cancer

  Free Subscription


Articles published in Clin Cancer Res

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    January 2012
  1. RIESTER M , Taylor J, Feifer A, Koppie TM, et al
    Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  2. REINERT T , Modin C, Mansilla Castano F, Lamy P, et al
    Comprehensive genome methylation analysis in bladder cancer;identification and validation of novel methylated genes and application of these as urinary tumor markers.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  3. YANG N , Feng S, Shedden K, Xie X, et al
    Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection using LC-MS/MS and Label-free Quantification.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  4. CHIONG E , Lee IL, Dadbin A, Sabichi AL, et al
    Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  5. SHAH JB , McConkey DJ, Dinney CP
    New Strategies in Muscle Invasive Bladder Cancer: On the Road to Personalized Medicine.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  6. MUGABE C , Matsui Y, So AI, Gleave ME, et al
    In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  7. KAWASHIMA A , Nakayama M, Kakuta Y, Abe T, et al
    Excision repair cross-complementing group 1 (ERCC1) may predict the efficacy of chemoradiotherapy for bladder cancer.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



  8. DUDZIEC E , Miah S, Choudhry H, Owen HC, et al
    Hypermethylation of CpG Islands and Shores around specific MicroRNAs and Mirtrons is associated with the phenotype and presence of Bladder Cancer.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



  9. SHIOTA M , Song Y, Yokomizo A, Kiyoshima K, et al
    Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.
    Clin Cancer Res. 2010;16:5654-63.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  10. COSTA VL , Henrique R, Danielsen SA, Duarte-Pereira S, et al
    Three epigenetic biomarkers, GDF15, TMEFF2 and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



  11. NAITO S , Bilim V, Kaori Y, Ugolkov A, et al
    Glycogen synthase kinase-3{beta}: a prognostic marker and a potential therapeutic target in human bladder cancer.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  12. SVATEK RS , Shariat SF, Lasky RE, Skinner EC, et al
    The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
    Clin Cancer Res. 2010;16:4461-7.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  13. LAUSS M , Ringner M, Hoglund M
    Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome Wide Expression Data: A Validation Study.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  14. SAEKI N , Gu J, Yoshida T, Wu X, et al
    Prostate stem cell antigen: a Jekyll and Hyde molecule?
    Clin Cancer Res. 2010;16:3533-8.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  15. MALMSTROM PU , Loskog AS, Lindqvist CA, Mangsbo SM, et al
    AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trial.
    Clin Cancer Res. 2010;16:3279-87.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  16. CARTHON BC , Wolchok JD, Yuan J, Kamat A, et al
    Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.
    Clin Cancer Res. 2010;16:2861-71.
    PubMed     Text format     Related articles    Abstract available



  17. MENGUAL L , Burset M, Ribal MJ, Ars E, et al
    Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.
    Clin Cancer Res. 2010;16:2624-33.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  18. ZUIVERLOON TC , van der Aa MN, van der Kwast T, Steyerberg EW, et al
    FGFR3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-grade Nonmuscle Invasive Bladder Cancer.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  19. KIM YJ , Ha YS, Kim SK, Yoon HY, et al
    Gene Signatures for the Prediction of Response to Bacillus Calmette-Guerin Immunotherapy in Primary pT1 Bladder Cancers.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  20. WILHELM CS , Kelsey KT, Butler R, Plaza S, et al
    Implications of LINE1 Methylation for Bladder Cancer Risk in Women.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: